CBD basics

Full-spectrum vs broad-spectrum vs isolate: what is the difference?

Written by: Author pendingReviewed by: Reviewer pendingUpdated:

Answer

Full-spectrum hemp extract keeps the plant's cannabinoids and terpenes, including delta-9 THC up to the 0.3 percent dry-weight federal ceiling in 7 U.S.C. 1639o. Broad-spectrum starts the same way, then has THC removed to non-detect. Isolate is one purified cannabinoid, usually CBD, with nothing else from the plant left in.

The three words describe how much of the hemp plant made it into the bottle. Nothing else about the product changes: the carrier oil, the serving size and the label math all work the same way. What changes is the cannabinoid profile, and with it the THC line on the certificate of analysis.

What does "spectrum" describe on a hemp label?

Answer

Hemp carries a long list of compounds. NCCIH notes that beyond THC and CBD, more than 100 other cannabinoids have been identified, plus terpenes and flavonoids. A full-spectrum extract keeps that whole mix, including the trace delta-9 THC that any compliant hemp plant carries. The Merck Veterinary Manual puts typical hemp CBD content at 0.3 to 4.2 percent of the plant, with THC capped at 0.3 percent by dry weight.

A broad-spectrum extract is a full-spectrum extract that has gone through an extra step to strip THC, usually chromatography. The other cannabinoids and most terpenes stay. The goal is a THC line that reads ND (not detected) at the lab's limit of quantitation.

An isolate is a single molecule. The processor crystallizes CBD (or CBG, or CBN) out of the extract and leaves everything else behind. An isolate COA shows one cannabinoid and a row of ND results for the rest.

Why does the THC line matter more after 2026?

Answer

Federal law is moving the goalposts. The amended definition of hemp in 7 U.S.C. 1639o switches from delta-9 THC to total tetrahydrocannabinols, "including tetrahydrocannabinolic acid," and excludes any final product containing more than 0.4 milligrams of total THC per container. The statute defines container as the innermost packaging in direct contact with the product. Public Law 119-103, signed September 2, 2026, delays most of those changes until December 11, 2026; only the clauses covering cannabinoids the plant cannot naturally produce take effect earlier, on November 12, 2026.

That cap lands on full-spectrum products first. A 30 mL full-spectrum tincture carries THC across the whole bottle, so the per-container total can clear 0.4 mg even when the percentage looks tiny. Broad-spectrum and isolate products that test ND at a low limit of quantitation are the formats built to survive that date.

The THC line also matters for workplace testing. In a crossover study published in the Journal of Analytical Toxicology, 100 mg of pure oral CBD produced no confirmed positive urine specimens at the 15 ng/mL federal confirmatory cutoff, while vaporized CBD-dominant cannabis carrying 3.7 mg of THC per dose produced 2 specimens that screened positive at 50 ng/mL. The spectrum you pick is a THC decision before it is anything else.

Is one spectrum proven better than the others?

Answer

The case for full-spectrum rests on the entourage effect, the idea that cannabinoids and terpenes work better together than alone. Russo proposed it in a 2011 review. A 2020 critical review in Expert Review of Clinical Pharmacology reached a harder verdict: "Claims of a cannabis entourage effect invoke ill-defined and unsubstantiated pharmacological activities," wrote Cogan, arguing that the concept is used more for marketing than it is supported by human data.

So the honest answer is that no controlled human trial has shown one spectrum outperforming another at a matched CBD dose. Full-spectrum buyers are choosing the whole-plant profile and accepting trace THC. Broad-spectrum buyers want the profile without THC. Isolate buyers want a single known molecule and the cleanest COA.

How do you tell which one you are holding?

Answer

Read the cannabinoid table on the COA, not the front label. Full-spectrum shows a delta-9 THC result above the limit of quantitation and usually several minor cannabinoids. Broad-spectrum shows ND for THC with other cannabinoids present. Isolate shows one cannabinoid near 99 percent purity on a potency basis and ND everywhere else. If the lab report does not list a limit of quantitation for THC, regard ND as unverified.

This page is general information, not personalized guidance.

General information, not personalized guidance.

Sources

  1. 7 U.S. Code 1639o - Definitions Cornell Law School, Legal Information Institute (accessed 2026-10-13)
  2. Public Law 119-103, Continuing Appropriations and Extensions Act, 2027 GovInfo (accessed 2026-10-13)
  3. Cannabis (Marijuana) and Cannabinoids: What You Need To Know NCCIH, National Institutes of Health (accessed 2026-10-13)
  4. Toxicosis in Dogs and Cats From Cannabidiol (CBD) Merck Veterinary Manual (accessed 2026-10-13)
  5. The 'entourage effect' or 'hodge-podge hashish' Expert Review of Clinical Pharmacology, via PubMed (accessed 2026-10-13)
  6. Urinary Pharmacokinetic Profile of Cannabinoids Following Administration of Vaporized and Oral Cannabidiol and Vaporized CBD-Dominant Cannabis Journal of Analytical Toxicology (accessed 2026-10-13)

Adults 21 and older

Are you 21 or older?

This store sells kratom and kava products to adults 21 and older. Every order is age-verified at checkout against public records, with a photo ID fallback. By continuing you confirm you are at least 21.